Previous close | 42.57 |
Open | 42.90 |
Bid | 43.20 x 1100 |
Ask | 43.21 x 1000 |
Day's range | 42.75 - 43.25 |
52-week range | 33.33 - 43.84 |
Volume | |
Avg. volume | 3,445,390 |
Market cap | 88.176B |
Beta (5Y monthly) | 0.27 |
PE ratio (TTM) | 15.84 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.47 (3.45%) |
Ex-dividend date | 16 May 2024 |
1y target est | N/A |
GSK ( LON:GSK ) First Quarter 2024 Results Key Financial Results Revenue: UK£7.36b (up 5.9% from 1Q 2023). Net income...
Emma Walmsley, chief executive officer of the pharmaceutical firm hailed a ‘strong start to 2024’.
Glaxo (GSK) delivered earnings and revenue surprises of 15.96% and 3.99%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?